« Return to News | CROs/Service Providers | Drug Sponsors

Delcath selects Quintiles to support EU launch of Chemosat

Wednesday, March 14, 2012 04:47 PM

Delcath Systems, an ongology-focused pharmaceutical company, has selected Quintiles to provide a specialized team of Medical Science Liaisons (MSLs) to support the launch of the Hepatic Chemosat Delivery System for the treatment of cancers in the liver in France, Germany, Italy, Netherlands, Spain, Ireland and the U.K. 

"This agreement gives us a highly professional medical science team in Europe with which we can begin communicating to and educating medical oncologists and liver specialists on the benefits of chemosaturation therapy," said Eamonn P. Hobbs, president and CEO of Delcath.

Comprised of medical doctors, nurses, pharmacologists and Ph.D. cancer specialists, the MSL team will draw on their understanding of the local healthcare environment and solid key opinion leader relationships to educate medical oncologists and hepatology specialists on the clinical benefits of the Chemosat system.

"The complexities in the European health care market can pose significant operational and market-place risk for companies based internationally and looking to launch here,” said Chris Pepler, head of commercial services in Europe, Middle East and Africa, Quintiles. “We're drawing on this local experience, alongside our consistent global standards of quality and delivery to provide comprehensive commercial solutions as Delcath launches their product in multiple markets across Europe."

Quintiles will also provide medical communication to support patient advocacy, key opinion leader development and field force materials.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.